These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9382729)
41. Role of lymphotoxins in the development of Peyer's patches and mesenteric lymph nodes: relevance to intestinal inflammation and treatment. Spahn TW; Müller MK; Domschke W; Kucharzik T Ann N Y Acad Sci; 2006 Aug; 1072():187-93. PubMed ID: 17057199 [TBL] [Abstract][Full Text] [Related]
42. Mucosal immunity in the female genital tract. Brandtzaeg P J Reprod Immunol; 1997 Nov; 36(1-2):23-50. PubMed ID: 9430737 [TBL] [Abstract][Full Text] [Related]
43. Dynamic interactions between bacteria and immune cells leading to intestinal IgA synthesis. Tsuji M; Suzuki K; Kinoshita K; Fagarasan S Semin Immunol; 2008 Feb; 20(1):59-66. PubMed ID: 18243016 [TBL] [Abstract][Full Text] [Related]
44. The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae. Snoeck V; Verfaillie T; Verdonck F; Goddeeris BM; Cox E Vaccine; 2006 May; 24(18):3812-20. PubMed ID: 16099554 [TBL] [Abstract][Full Text] [Related]
45. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues. Hiroi T; Yanagita M; Iijima H; Iwatani K; Yoshida T; Takatsu K; Kiyono H J Immunol; 1999 Jan; 162(2):821-8. PubMed ID: 9916704 [TBL] [Abstract][Full Text] [Related]
46. [Immune barriers of the mucous membrane of the upper respiratory and digestive tracts]. Brandtzaeg P Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):225-36. PubMed ID: 3497320 [TBL] [Abstract][Full Text] [Related]
47. Lack of relation between expression of HLA-DR and secretory component (SC) in follicle-associated epithelium of human Peyer's patches. Bjerke K; Brandtzaeg P Clin Exp Immunol; 1988 Mar; 71(3):502-7. PubMed ID: 3289802 [TBL] [Abstract][Full Text] [Related]
48. New generation of mucosal adjuvants for the induction of protective immunity. Yuki Y; Kiyono H Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340 [TBL] [Abstract][Full Text] [Related]
49. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity. Fleeton M; Contractor N; Leon F; He J; Wetzel D; Dermody T; Iwasaki A; Kelsall B Ann N Y Acad Sci; 2004 Dec; 1029():60-5. PubMed ID: 15681744 [TBL] [Abstract][Full Text] [Related]
50. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Kaetzel CS Immunol Rev; 2005 Aug; 206():83-99. PubMed ID: 16048543 [TBL] [Abstract][Full Text] [Related]
51. Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM: studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. Natvig IB; Johansen FE; Nordeng TW; Haraldsen G; Brandtzaeg P J Immunol; 1997 Nov; 159(9):4330-40. PubMed ID: 9379029 [TBL] [Abstract][Full Text] [Related]
52. The secretory IgA system and mucosal defence. Hanson LA; Andersson B; Carlsson B; Cruz JR; Dahlgren U; Baltzer IM; Edén CS Scand J Infect Dis Suppl; 1980; Suppl 24():13-21. PubMed ID: 7010551 [No Abstract] [Full Text] [Related]
54. Mucosal immunization via M cells for production of protective secretory IgA antibodies. Neutra MR; Kraehenbuhl JP Am J Trop Med Hyg; 1994; 50(5 Suppl):10-3. PubMed ID: 8203718 [TBL] [Abstract][Full Text] [Related]